Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

11. LOANS RECEIVABLE: Schedule of Loans Receivable (Details)

v3.21.2
11. LOANS RECEIVABLE: Schedule of Loans Receivable (Details) - CAD ($)
Dec. 31, 2020
Dec. 31, 2019
Loans receivable [1] $ 51,676,623 $ 36,504,397
Advances to PharmaCo Inc    
Loans receivable 11,084,278 4,381,329
Promissory note receivable from PharmaCo Inc    
Loans receivable 32,627,616 30,648,517
Promissory note acquired with RTO    
Loans receivable [2] 4,231,664 0
Accrued interest on promissory note acquired with RTO    
Loans receivable [2] 686,288 0
Net receivable from sellers of Platinum Vape    
Loans receivable [3] 3,046,777 0
Settlement of preexisting relationship in MAG acquisition    
Loans receivable [3] $ 0 $ 1,474,551
[1] Note 11.
[2] Note 5.
[3] Note 6.